Shopping Cart
- Remove All
Your shopping cart is currently empty
DCZ3301 is a novel aryl-guanidino inhibitor.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $70 | In Stock | |
| 5 mg | $161 | In Stock | |
| 10 mg | $237 | In Stock | |
| 25 mg | $355 | In Stock | |
| 50 mg | $500 | In Stock | |
| 100 mg | $672 | In Stock | |
| 200 mg | $890 | In Stock | |
| 1 mL x 10 mM (in DMSO) | $178 | In Stock |
| Description | DCZ3301 is a novel aryl-guanidino inhibitor. |
| In vitro | Jurkat and HUT78 cells was markedly inhibited by DCZ3301 treatment in a time- and dose- dependent manner, IC50 values for Jurkat and HUT78 cells were 3.02 μM and 9.42 μM, respectively, after DCZ3301 treatment for 48 h. |
| Synonyms | NPS ALX Compound 4a hydrochloride(1:1)(299433-10-6 Free base) |
| Molecular Weight | 464.83 |
| Formula | C20H16ClF3N6O2 |
| Cas No. | 2136278-38-9 |
| Smiles | O(C=1C=C(C(NC)=O)N=CC1)C=2C=CC(NC(NC3=CC(C(F)(F)F)=C(Cl)C=C3)=N)=NC2 |
| Color | White |
| Appearance | Solid |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 50 mg/mL (107.57 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.